China Pharma Holdings - 15 Year Stock Price History | CPHI
Historical daily share price chart and data for China Pharma Holdings since 2011 adjusted for splits and dividends. The latest closing stock price for China Pharma Holdings as of June 18, 2026 is 0.77.
- The all-time high China Pharma Holdings stock closing price was 251.00 on July 08, 2011.
- The China Pharma Holdings 52-week high stock price is 2.03, which is 163.6% above the current share price.
- The China Pharma Holdings 52-week low stock price is 0.38, which is 50.6% below the current share price.
- The average China Pharma Holdings stock price for the last 52 weeks is 1.26.
| China Pharma Holdings Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2026 | 0.7733 | 1.2100 | 1.3600 | 0.5200 | 0.7711 | -36.27% |
| 2025 | 1.8582 | 2.3900 | 2.9490 | 1.2100 | 1.2100 | -47.96% |
| 2024 | 2.2895 | 1.1670 | 4.2500 | 0.6900 | 2.3250 | 92.15% |
| 2023 | 3.7869 | 8.7000 | 11.6900 | 0.8930 | 1.2100 | -87.38% |
| 2022 | 25.0124 | 45.8300 | 49.9500 | 9.4851 | 9.5900 | -80.13% |
| 2021 | 70.7519 | 49.0000 | 128.0000 | 41.0000 | 48.2600 | 8.25% |
| 2020 | 47.7501 | 24.7500 | 114.0000 | 24.7500 | 44.5800 | 88.26% |
| 2019 | 28.3586 | 24.0000 | 50.7000 | 22.2100 | 23.6800 | -8.00% |
| 2018 | 28.7640 | 17.3000 | 57.9900 | 17.1900 | 25.7400 | 46.58% |
| 2017 | 21.2774 | 25.4200 | 29.0000 | 15.0000 | 17.5600 | -32.46% |
| 2016 | 21.1852 | 16.4200 | 31.9500 | 12.0000 | 26.0000 | 65.71% |
| 2015 | 28.0154 | 31.0000 | 42.0000 | 15.5800 | 15.6900 | -47.72% |
| 2014 | 38.5597 | 36.0000 | 78.5000 | 20.5000 | 30.0100 | -13.01% |
| 2013 | 27.0134 | 26.0000 | 47.0000 | 19.0100 | 34.5000 | 70.79% |
| 2012 | 45.1813 | 67.6000 | 82.0000 | 19.0000 | 20.2000 | -69.85% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $0.026B | $0.004B |
| CHINA PHARMA HOLDINGS, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular and CNS diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd. (Helpson), a specialty pharmaceutical company headquartered in Haikou City, Hainan province in China, is a wholly owned subsidiary of China Pharma Holdings. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $35.437B | 10.97 |
| BridgeBio Pharma (BBIO) | United States | $14.460B | 0.00 |
| Dr Reddy's Laboratories (RDY) | India | $11.109B | 17.29 |
| Aspen Pharmacare (APNHY) | South Africa | $3.708B | 0.00 |
| Supernus Pharmaceuticals (SUPN) | United States | $2.918B | 22.33 |
| Bausch Health Cos (BHC) | Canada | $2.086B | 1.50 |
| Taysha Gene Therapies (TSHA) | United States | $1.290B | 0.00 |
| Amphastar Pharmaceuticals (AMPH) | United States | $0.924B | 7.28 |
| Personalis (PSNL) | United States | $0.630B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.451B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.210B | 0.00 |
| Metagenomi Therapeutics (MGX) | United States | $0.052B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.019B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |